Anavex Life Sciences
AVXL
#8124
Rank
NZ$0.48 B
Marketcap
NZ$5.23
Share price
-3.55%
Change (1 day)
-65.01%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.93

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.94. a decrease over its 2024 EPS that were of NZ-$0.91.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.943.85%
2024NZ-$0.91-13.33%
2023NZ-$1.05-3.23%
2022NZ-$1.0814.81%
2021NZ-$0.9420%
2020NZ-$0.79-16.67%
2019NZ-$0.9438.46%
2018NZ-$0.6818.18%
2017NZ-$0.58-21.43%
2016NZ-$0.73-35.38%
2015NZ-$1.14-36.27%
2014NZ-$1.78112.5%
2013NZ-$0.84-58.62%
2012NZ-$2.03-0%
2011NZ-$2.03-29.27%
2010NZ-$2.8751.85%
2009NZ-$1.89-0%
2008NZ-$1.89237.5%
2007NZ-$0.56
2006N/A-100%
2005NZ-$0.06996499.97%
2004NZ-$0.01166

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$11.02-1,266.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.64-274.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$52.30 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08745-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA